Applied Spectral Imaging, WaveSense enter into agreement

Applied Spectral Imaging (ASI) and WaveSense have entered into an agreement in which both companies will sell and market the GenASIs imaging and analysis instrument from ASI and the EpiSEP cell recovery and enrichment solution from WaveSense as one system.

Applied Spectral Imaging (ASI; Carlsbad, CA) and WaveSense (Irvine, CA) have entered into an agreement in which both companies will sell and market the GenASIs imaging and analysis instrument from ASI and the EpiSEP cell recovery and enrichment solution from WaveSense as one system. Combined, the two products yield an integrated cell capturing solution and computerized instrument to detect, image, and analyze captured cells.

The two companies have confirmed the combined solution's effectiveness in performing semi-automated fluorescence in situ hybridization (FISH) analysis of paramagnetic labeled target cells. Target cells may be retrieved, enriched, imaged, and analyzed in urine, bone marrow, blood, needle aspiration, abdominal ascites, lymph node, culture, and pleural effusion specimens.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

More in Fluorescence